cancer doctors

Melanoma Cancer Center

Question: I recently had a biopsy on a spot on my hip. It came back no melanoma but they are sending me to a cancer? center to see an oncologist because they are not sure what it is. 4 different pathologist have looked at it and all of them said to get a further opinion. It was a red mark about 1in. long & 1/2 in. wide. It didn't bother me and wasn't sore but when you pressed on it you could fill a hard core and it concerned my doctor so she removed it. She said that is was very vascular when whe got in there to take it out. I'm just concerned that they say it was not melanoma but now they are sending me to a cancer center. What could it be???

Answer: I have an area in my eye that is very vascular - it is just watched and has never done anything for 30 years. My friend has a vascular growth on her liver - has a scan every year but it too has not done anything more. Just keep in mind that if all you have is a hammer, then every thing gets treated like a n ail. An oncologist treats cancers with poisons - he has nothing else to offer. Do as much research as you can. Good luck.


Melanoma Cancer Center News

Scientists find molecular switch that allows melanoma to resist therapy

Medical Xpress
Credit: Ronai lab, Sanford-Burnham Medical Research Institute The National Cancer Institute (NCI) estimates that as many as one in 51 men and women will be diagnosed with melanoma?the deadliest form of skin cancer?at some point during their lifetimes.
 

Melanoma Drug Resistance Linked to Kinase Control of Transcription Factor Activity

Genetic Engineering News
... which can play an oncogenic role in melanoma but a tumor suppressor role in nonmalignant skin cancers. A team at Sanford-Burnham Medical Research Institute, Yale University, the University of California, San Diego, and Ajou University School of ...
 

ABC News

Lots of Fun in the Sun, but Little Use of Sunscreen by Kids
ABC News
 

eMaxHealth

Study uncovers mechanism by which melanoma drug accelerates secondary skin cancers
Medical Xpress
 

Newly-Approved Melanoma Drug Vemurafenib Accelerates Secondary Skin Cancers

EmpowHer
Now researchers at UCLA's Jonsson Comprehensive Cancer Center, working with investigators from the Institute of Cancer Research in London and drug makers Roche and Plexxikon, have new understanding of how vemurafenib's melanoma-fighting mechanism also ...
 

How new melanoma drug accelerates secondary skin cancers

ScienceBlog.com (blog)
Now, researchers at UCLA's Jonsson Comprehensive Cancer Center, working with investigators from the Institute of Cancer Research in London, Roche and Plexxikon, have elucidated the mechanism by which the drug excels at fighting melanoma but also allows ...
 

Nonmelanoma Lung Lesions in Melanoma Patients

Medscape
The findings, from 229 patients with metastatic melanoma treated at the Memorial Sloan-Kettering Cancer Center in New York City, were published online last year in the Annals of Oncology. The "initially surprising high incidence of nonmelanoma ...
 

Lawmaker Calls for Bipartisan Support for Cancer Research

Medscape
Making cancer research a national priority is something all lawmakers can get behind, he explained, adding that it isn't a question of being on the right, the left, or the center. "You just have to be on the field and take responsibility for your part ...
 

Investigators seek clues to resistance to melanoma drug

Vanderbilt University News
26, 2012 ? 5:10 PM Lentigo Maligna Melanoma on a man's forehead. There are two stitches holding the biopsy site together. (iStock) Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why ...
 

Delcath Announces First European Chemosat Procedures

Sacramento Bee
Two patients were treated for inoperable liver-dominant metastases from ocular melanoma and gastric cancer. All CHEMOSAT procedures were successfully completed without procedure-related complications. Delcath and the IEO will host a joint-press ...
 

Types of Cancer


Adrenal Cancer Anal Cancer Brain Cancer Colorectal Cancer Endometrial Cancer Esophageal Cancer
Esophageal Cancer Laryngeal Cancer Oral Cancer Penile Cancer Prostatic Cancer Stomach Cancer
Thyroid Cancer Bladder Cancer Bone Cancer Cervix Cancer Heart Cancer Kidney Cancer
Melanoma Cancer Pancreas Cancer Asbestos Cancer